PEMETREXED 100 mg/4mL

Pemetrexed 100 mg/4mL is a lyophilized powder for solution, used for intravenous administration. This medication is commonly associated with certain types of cancer treatments. Accord Healthcare Inc. manufactures this product in the USA.

Pemetrexed is primarily used in the treatment of specific types of cancer. It works by interfering with the growth and spread of cancer cells in the body. Pemetrexed is often administered as part of a combination therapy regimen. Patients and healthcare providers typically discuss what Pemetrexed is used for based on individual medical histories and treatment plans.

Common effects of Pemetrexed may include fatigue, nausea, and vomiting. Some patients may experience a decrease in blood cell counts, which can lead to increased susceptibility to infections. It is important to monitor for any unusual symptoms and report them to a healthcare provider.

Pemetrexed should be handled with care, as it is a potent medication. It is essential to follow proper storage and administration guidelines to ensure safety. Patients should inform their healthcare provider about any allergies or pre-existing conditions before starting treatment. Proper hydration and supplementation may be recommended to mitigate certain side effects.

Pemetrexed may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and certain vitamins. Alcohol consumption should be avoided during treatment. Patients should consult their healthcare provider about all medications they are taking to avoid potential interactions.